bpc-157 clinical trial human Pentadecapeptide BPC 157, in Trials as a Therapy for Inflammatory Bowel Disease (PL14736), Is Effective in the Healing bpc-157 human clinical trials evidence
Description
12,40 Clinical safety and efficacy evaluations were conducted over a 6-month follow-up period (180 14 days)
Dosing adjusted based on response
2014;134:e700e9
Symptoms include: Symptoms are more likely to be present or get worse when you stand or walk
doi: 10.1093/ofid/ofaa407 49 CheungCYPoonLLNgIHLukWSiaSFWuMHet al
BPC-157 alone makes sense when: you have an isolated injury (specific tendon, recovering surgical site, gut-lining concerns from NSAID use), or you want to evaluate how BPC-157 affects you before adding another peptide
